-
Signature
-
/s/ John B. Moriarty, Jr., J.D., Attorney-in-Fact
-
Stock symbol
-
RNA
-
Transactions as of
-
Aug 28, 2025
-
Transactions value $
-
-$1,203,700
-
Form type
-
4
-
Date filed
-
8/29/2025, 04:28 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Boyce Sarah |
President and CEO, Director |
C/O AVIDITY BIOSCIENCES, INC., 10578 SCIENCE CENTER DRIVE, SUITE 125, SAN DIEGO |
/s/ John B. Moriarty, Jr., J.D., Attorney-in-Fact |
2025-08-29 |
0001629383 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RNA |
Common Stock |
Options Exercise |
$31K |
+25K |
+8.17% |
$1.24 |
331K |
Aug 28, 2025 |
Direct |
F1 |
| transaction |
RNA |
Common Stock |
Sale |
-$1.23M |
-25K |
-7.56% |
$49.39 |
306K |
Aug 28, 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RNA |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-25K |
-2.28% |
$0.00 |
1.07M |
Aug 28, 2025 |
Common Stock |
25K |
$1.24 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: